4//SEC Filing
Kaye Randall 4
Accession 0000950170-24-118315
CIK 0001832168other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 4:43 PM ET
Size
6.1 KB
Accession
0000950170-24-118315
Insider Transaction Report
Form 4
Kaye Randall
CMO
Transactions
- Award
Retention Restricted Stock Units
2024-10-25+9,500→ 9,500 totalExercise: $0.00→ Voting Common Stock (9,500 underlying)
Footnotes (1)
- [F1]The retention restricted stock units ("Retention RSUs") vest in full on the earlier of October 25, 2025, or the date of the Reporting Person's Involuntary Termination (as defined in the Reporting Person's employment agreement) (such earlier date, the "Vesting Date"). The shares underlying the Retention RSUs will be issued upon vesting and release of the Retention RSUs. If the acquisition of the Issuer pursuant to the Agreement and Plan of Merger attached as Exhibit 2.1 to the Issuer's Current Report on Form 8-K filed with the SEC on October 15, 2024 (the "Merger Agreement") is completed prior to the Vesting Date, then, as of and following the Effective Time (as defined in the Merger Agreement), the Retention RSUs shall be settled via payment of an amount in cash, without interest, equal to the product of the Merger Consideration (as defined in the Merger Agreement) multiplied by the number of Retention RSUs, with such amount payable to the Reporting Person on the Vesting Date.
Documents
Issuer
Longboard Pharmaceuticals, Inc.
CIK 0001832168
Entity typeother
Related Parties
1- filerCIK 0001350416
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 4:43 PM ET
- Size
- 6.1 KB